BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37334356)

  • 21. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer.
    Badoual C; Bouchaud G; Agueznay Nel H; Mortier E; Hans S; Gey A; Fernani F; Peyrard S; -Puig PL; Bruneval P; Sastre X; Plet A; Garrigue-Antar L; Quintin-Colonna F; Fridman WH; Brasnu D; Jacques Y; Tartour E
    Cancer Res; 2008 May; 68(10):3907-14. PubMed ID: 18483276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4
    Awad RM; De Vlaeminck Y; Meeus F; Ertveldt T; Zeven K; Ceuppens H; Goyvaerts C; Verdonck M; Salguero G; Raes G; Devoogdt N; Breckpot K
    Sci Rep; 2023 Nov; 13(1):18995. PubMed ID: 37923822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα production.
    Yokota S; Yoshida O; Dou L; Spadaro AV; Isse K; Ross MA; Stolz DB; Kimura S; Du Q; Demetris AJ; Thomson AW; Geller DA
    J Immunol; 2015 Jun; 194(12):6045-56. PubMed ID: 25964490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect
    Silvestre RN; Eitler J; de Azevedo JTC; Tirapelle MC; Fantacini DMC; de Souza LEB; Swiech K; Covas DT; Calado RT; Montero PO; Malmegrim KCR; Figueiredo ML; Tonn T; Picanço-Castro V
    Front Immunol; 2023; 14():1226518. PubMed ID: 37818365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice.
    Shi Y; Dincheva-Vogel L; Ayemoba CE; Fung JP; Bergamaschi C; Pavlakis GN; Farzaneh F; Gaensler KML
    Blood Adv; 2018 Nov; 2(22):3177-3192. PubMed ID: 30482760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17).
    Budagian V; Bulanova E; Orinska Z; Ludwig A; Rose-John S; Saftig P; Borden EC; Bulfone-Paus S
    J Biol Chem; 2004 Sep; 279(39):40368-75. PubMed ID: 15215246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
    Votavova P; Tomala J; Kovar M
    Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
    Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
    Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning and expression analysis of interleukin (IL)-15 and IL-15 receptor α from rock bream, Oplegnathus fasciatus.
    Bae JS; Shim SH; Hwang SD; Kim JW; Park DW; Park CI
    Fish Shellfish Immunol; 2013 Oct; 35(4):1209-15. PubMed ID: 23911652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paracrine and transpresentation functions of IL-15 are mediated by diverse splice versions of IL-15Rα in human monocytes and dendritic cells.
    Müller JR; Waldmann TA; Kruhlak MJ; Dubois S
    J Biol Chem; 2012 Nov; 287(48):40328-38. PubMed ID: 23074221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors.
    Giron-Michel J; Giuliani M; Fogli M; Brouty-Boyé D; Ferrini S; Baychelier F; Eid P; Lebousse-Kerdilès C; Durali D; Biassoni R; Charpentier B; Vasquez A; Chouaib S; Caignard A; Moretta L; Azzarone B
    Blood; 2005 Oct; 106(7):2302-10. PubMed ID: 15976182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells.
    Robinson TO; Hegde SM; Chang A; Gangadharan A; Rivas S; Madakamutil L; Zalevsky J; Miyazaki T; Schluns KS
    J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34375310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation.
    Wu Z; Xue HH; Bernard J; Zeng R; Issakov D; Bollenbacher-Reilley J; Belyakov IM; Oh S; Berzofsky JA; Leonard WJ
    Blood; 2008 Dec; 112(12):4411-9. PubMed ID: 18796634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Interleukin IL-15Ralpha is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15.
    Bulanova E; Budagian V; Duitman E; Orinska Z; Krause H; Rückert R; Reiling N; Bulfone-Paus S
    J Biol Chem; 2007 May; 282(18):13167-79. PubMed ID: 17327231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.
    Fregni G; Messaoudene M; Fourmentraux-Neves E; Mazouz-Dorval S; Chanal J; Maubec E; Marinho E; Scheer-Senyarich I; Cremer I; Avril MF; Caignard A
    PLoS One; 2013; 8(10):e76928. PubMed ID: 24204708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
    He YG; Mayhew E; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models.
    Guo S; Smeltz RB; Nanajian A; Heller R
    Front Immunol; 2020; 11():614667. PubMed ID: 33628206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunomodulatory effects of spleenic cells added by sIL-15Ralpha on the regulation of melanoma cell growth].
    Gu YH; Wang RS; Shu YQ; Xu Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):847-9. PubMed ID: 18782512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity.
    Bergamaschi C; Rosati M; Jalah R; Valentin A; Kulkarni V; Alicea C; Zhang GM; Patel V; Felber BK; Pavlakis GN
    J Biol Chem; 2008 Feb; 283(7):4189-99. PubMed ID: 18055460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.